TRINET GROUP, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TRINET GROUP, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.01B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $5.05B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $4.99B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $4.91B | Feb 13, 2025 |
| FY2018 | Dec 31, 2018 | $917.00M | Feb 14, 2019 |
| FY2018 | Sep 30, 2018 | $875.00M | Feb 14, 2019 |
| FY2018 | Jun 30, 2018 | $850.00M | Feb 14, 2019 |
| FY2018 | Mar 31, 2018 | $861.00M | Feb 14, 2019 |
| FY2018 | Dec 31, 2017 | $848.00M | Feb 14, 2019 |
| FY2018 | Sep 30, 2017 | $818.00M | Feb 14, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $4.92B | Feb 15, 2024 |
| FY2023 | Dec 31, 2022 | $4.89B | Feb 15, 2024 |
| FY2023 | Dec 31, 2021 | $4.54B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $4.03B | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | $1.02B | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | $969.00M | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | $935.00M | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | $934.00M | Feb 13, 2020 |
| FY2019 | Dec 31, 2018 | $917.00M | Feb 13, 2020 |
| FY2019 | Sep 30, 2018 | $875.00M | Feb 13, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $155.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $173.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $375.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $355.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $338.00M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $272.00M | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | $48.00M | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | $55.00M | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | $46.00M | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | $63.00M | Feb 13, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $469.00M | Feb 15, 2024 |
| FY2023 | Dec 31, 2022 | $499.00M | Feb 15, 2024 |
| FY2023 | Dec 31, 2021 | $455.00M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $368.00M | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | $63.00M | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | $68.00M | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | $55.00M | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | $82.00M | Feb 13, 2020 |
| FY2019 | Dec 31, 2018 | $42.00M | Feb 13, 2020 |
| FY2019 | Sep 30, 2018 | $62.00M | Feb 13, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $68.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $65.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $73.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $50.00M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $40.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $43.00M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $49.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $45.00M | Feb 13, 2020 |
| FY2018 | Dec 31, 2016 | $31.00M | Feb 14, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $303.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $279.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $539.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $497.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $218.00M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $546.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $471.00M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | ($104.00M) | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $606.00M | Feb 13, 2020 |
| FY2018 | Dec 31, 2016 | $192.00M | Feb 14, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $69.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $78.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $75.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $56.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $40.00M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $36.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $45.00M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $43.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $38.00M | Feb 13, 2020 |
| FY2018 | Dec 31, 2016 | $40.00M | Feb 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.80B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $4.12B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $3.69B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $3.44B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $3.31B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $3.04B | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $2.75B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $2.44B | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $2.59B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $2.10B | Feb 27, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.74B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $4.05B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $3.62B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $2.67B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $2.43B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $2.44B | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $2.27B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $2.06B | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $2.39B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $2.06B | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $69.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $78.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2022 | $775.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2021 | $881.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2020 | $607.00M | Feb 15, 2024 |
| FY2022 | Dec 31, 2019 | $475.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2018 | $375.00M | Feb 14, 2022 |
| FY2020 | Dec 31, 2017 | $206.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2016 | $35.00M | Feb 13, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $461.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $461.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $462.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $462.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $294.00M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $294.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $289.00M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $289.00M | Feb 16, 2021 |
| FY2018 | Dec 31, 2017 | $289.00M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $289.00M | Feb 27, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.08B) | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | ($984.00M) | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | ($896.00M) | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | ($119.00M) | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $74.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | ($144.00M) | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | ($219.00M) | Feb 16, 2021 |
| FY2020 | Dec 30, 2019 | ($219.00M) | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | ($266.00M) | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | ($377.00M) | Feb 14, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $287.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $360.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $287.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $354.00M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $612.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $301.00M | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $213.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $228.00M | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $336.00M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $184.00M | Feb 27, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | 4 | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 13, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 13, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 47.38M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 49.53M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 50.66M | Feb 12, 2026 |
| FY2025 | Dec 31, 2022 | 60.56M | Feb 12, 2026 |
| FY2024 | Dec 31, 2021 | 65.97M | Feb 13, 2025 |
| FY2023 | Dec 31, 2020 | 66.46M | Feb 15, 2024 |
| FY2022 | Dec 31, 2019 | 69.07M | Feb 15, 2023 |
| FY2021 | Dec 31, 2018 | 70.60M | Feb 14, 2022 |
| FY2020 | Dec 31, 2017 | 69.82M | Feb 16, 2021 |
| FY2017 | Dec 31, 2016 | 69.02M | Feb 27, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $37.00M | Feb 12, 2026 |